- Report
- July 2025
- 220 Pages
Global
From €4390EUR$4,995USD£3,798GBP
- Report
- June 2025
- 101 Pages
Global
From €3032EUR$3,450USD£2,623GBP
- Report
- June 2025
- 135 Pages
Global
From €3624EUR$4,123USD£3,134GBP
€4263EUR$4,850USD£3,687GBP
- Report
- May 2025
- 191 Pages
Global
From €4351EUR$4,950USD£3,763GBP
- Report
- May 2025
- 102 Pages
Global
From €2593EUR$2,950USD£2,243GBP
- Report
- April 2025
- 135 Pages
Global
From €3624EUR$4,123USD£3,134GBP
€4263EUR$4,850USD£3,687GBP
- Report
- April 2025
- 210 Pages
Global
From €3955EUR$4,500USD£3,421GBP
- Report
- April 2025
- 180 Pages
Global
From €3624EUR$4,123USD£3,134GBP
€4263EUR$4,850USD£3,687GBP
- Report
- March 2025
- 131 Pages
Global
From €3624EUR$4,123USD£3,134GBP
€4263EUR$4,850USD£3,687GBP
- Report
- February 2025
- 130 Pages
Global
From €3624EUR$4,123USD£3,134GBP
€4263EUR$4,850USD£3,687GBP
- Report
- January 2025
- 220 Pages
Global
From €4390EUR$4,995USD£3,798GBP
- Report
- October 2024
- 93 Pages
Global
From €3955EUR$4,500USD£3,421GBP
- Report
- June 2025
- 100 Pages
United States
From €3076EUR$3,500USD£2,661GBP
- Report
- January 2025
- 120 Pages
United States
From €2189EUR$2,490USD£1,893GBP
- Report
- March 2025
- 200 Pages
United States
From €2189EUR$2,490USD£1,893GBP
- Report
- August 2025
- 121 Pages
United States
From €2636EUR$2,999USD£2,280GBP
- Report
- February 2025
- 146 Pages
Middle East
From €2636EUR$2,999USD£2,280GBP
- Report
- November 2024
- 85 Pages
United States
From €3076EUR$3,500USD£2,661GBP
- Report
- July 2025
- 250 Pages
North America
From €3401EUR$3,869USD£2,942GBP
- Report
- July 2025
- 250 Pages
Middle East, Africa
From €3401EUR$3,869USD£2,942GBP

Injectables and infusions are medical treatments that involve the administration of drugs or other substances directly into the body. Injectables are typically administered through a needle or syringe, while infusions are typically administered through a catheter or intravenous line. Injectables and infusions are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases.
The injectable market is a rapidly growing segment of the pharmaceutical industry. It is estimated that the global injectable market is worth over $100 billion and is expected to grow at a compound annual growth rate of over 8%. The market is driven by the increasing prevalence of chronic diseases, the growing demand for biologics, and the increasing use of self-injectable drugs.
Some of the major players in the injectable market include Pfizer, Merck, Sanofi, Novartis, and Johnson & Johnson. Other companies in the market include Amgen, Bristol-Myers Squibb, Eli Lilly, and AstraZeneca. Show Less Read more